Back to search

Article

A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1

2020-08-14

Abstract excerpt

<h4>Background</h4> A combination of central muscle relaxants, chlorzoxazone and baclofen (chlorzoxazone-baclofen), has been proposed for treatment of cerebellar symptoms in human spinocerebellar ataxia (SCA). However, central muscle relaxants can worsen balance. The optimal dose for target engagement without toxicity remains unknown. <h4>Objectives</h4> Using the genetically precise Atxn1 154Q/2Q model of SCA1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
88ac0ac3-4439-586a-95b7-7bfd08026714
DOI
10.1101/2020.08.14.251330
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1DOI 10.1101/2020.08.14.251330
Select a neighboring publication to make it the new centre.